MCL1 and neuroblastoma: Knockdown or biochemical inhibition of the spliceosome component U2 snRNP SF3B1 also favors MCL1 splicing toward the pro-apoptotic MCL1S variant and sensitizes MCL1-dependent neuroblastoma cells to ABT-737 [51].